Research use only

Laboratory note

GIP / GLP-1 / glucagon receptor primer (RUO)

GIPR, GLP-1R, and GCGR shorthand

For laboratory research use only. Not for human or veterinary use, consumption, compounding into a medicine, or injection. Not authorized by Health Canada. Literature on this page is scientific context only. This page is not a licensed drug, a wellness protocol, or a dosing guide.

GIPR appears in dual and triple classes. GLP-1R appears in all three catalog classes. GCGR is the triple-class differentiator.

How the catalog maps

Semaglutide is the GLP-1 receptor analogue on this catalog (CAS 910463-68-2). Tirzepatide is the GIPR plus GLP-1R analogue (CAS 2023788-19-2). Retatrutide is the GIPR plus GLP-1R plus GCGR analogue (CAS 2381089-83-2).

Yamanouchi (2025) reviews GIP and GLP-1. Lau, Coskun (2018), and Coskun (2022) are the discovery anchors for the three classes. They are literature context.

Email request@pharmapeptidesrx.com and name the compound. This primer does not name a lot.

In this library

Bench reconstitution

Reconstitution belongs on the compound brief, in bacteriostatic water, at the concentration the protocol specifies.

Diluent page: bacteriostatic water.

PubMed

Selected literature

  • PMID 41515907 (2025) Yamanouchi, International Journal of Molecular Sciences — GIP and GLP-1 review (class context, not a compound-primary analytical paper)
  • PMID 26308095 (2015) Lau et al., Journal of Medicinal Chemistry — semaglutide discovery
  • PMID 30473097 (2018) Coskun et al., Molecular Metabolism — LY3298176 dual GIP/GLP-1 agonist discovery / proof of concept
  • PMID 35985340 (2022) Coskun et al., Cell Metabolism — LY3437943 discovery / proof of concept (triple glucagon, GIP, GLP-1)

Literature is scientific context only. A paper does not make a research vial into a licensed medicine.

Certificate of analysis

Ask request@pharmapeptidesrx.com for the lot-matched COA of a named compound. This primer is not a COA.

Lab FAQ

Does glucagon-receptor shorthand mean the dual-agonist page is incomplete?

No. Glucagon-receptor engagement is the triple-agonist differentiator. Email request@pharmapeptidesrx.com and name the analogue you need. This page does not name a lot.

Laboratory inquiry

Write request@pharmapeptidesrx.com

Questions about this note go to request@pharmapeptidesrx.com from the laboratory account. Research use only.